Danaher Co. (NYSE:DHR) is Broderick Brian C’s 10th Largest Position

Broderick Brian C grew its position in shares of Danaher Co. (NYSE:DHR) by 0.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 62,410 shares of the conglomerate’s stock after acquiring an additional 82 shares during the quarter. Danaher comprises 3.4% of Broderick Brian C’s portfolio, making the stock its 10th biggest position. Broderick Brian C’s holdings in Danaher were worth $17,351,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Fort Pitt Capital Group LLC boosted its position in Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after purchasing an additional 7,421 shares during the period. Good Life Advisors LLC purchased a new stake in Danaher during the 3rd quarter worth $217,000. Oak Thistle LLC acquired a new position in shares of Danaher in the second quarter worth about $363,000. Harvest Portfolios Group Inc. boosted its holdings in Danaher by 1.2% in the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after purchasing an additional 2,465 shares during the last quarter. Finally, Diversified Trust Co increased its holdings in Danaher by 75.4% during the 2nd quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate’s stock worth $1,090,000 after purchasing an additional 1,874 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 11.10% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

DHR has been the subject of a number of research analyst reports. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a research note on Thursday, October 31st. Stephens reiterated an “overweight” rating and set a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Barclays dropped their price target on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI boosted their price target on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Finally, Robert W. Baird cut their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $287.16.

Danaher Trading Down 0.9 %

Shares of DHR stock opened at $239.45 on Friday. The stock has a 50-day simple moving average of $263.42 and a 200 day simple moving average of $260.64. The stock has a market capitalization of $172.95 billion, a P/E ratio of 45.70, a P/E/G ratio of 4.44 and a beta of 0.85. Danaher Co. has a fifty-two week low of $204.15 and a fifty-two week high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter last year, the firm posted $2.02 EPS. On average, sell-side analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.